Related Experiment Video
Updated: Aug 6, 2026

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
Published on: November 12, 2010
[Antidepressants: TCA versus SSRI versus other new agents]
1Service de Psychiatrie, Hôpital Erasme, ULB, Bruxelles.
Abstract:
The medications that appeared in the last two decades, offer praticians a wider choice than ever in the treatment of major depressive disorders. The aim of this article was first to compare tricyclic antidepressants and serotonine selective reuptake inhibitors. It was quite obvious that it was impossible to take no account of the birth of newer antidepressants. So we reviewed the efficacy--throughout their mechanims of action--of those different antidepressive agents, as well as their side-effects. One could think that the coming-out of molecules simpler to use, would facilitate the prescription. In fact, it does and it doesn't; it allows praticians, more than before, to accord with their clinical touch. That means that, at comparable efficacy, we now can choose therapeutic agents that fit more adequately a particular patient, his/her characteristics as well as his/her somatic and psychiatric history.
Related Concept Videos
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Therapy
Antianxiety Medications
Electroconvulsive Therapy

